European Commission warned not to "rush" update to counterfeit drugs directive
The amendments to the EU directive covering counterfeit medicines must not be rushed through, the former member of the European Parliament who made the proposals has told WTR.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.